Schizophrenia Research

Article	Citations
Elevated triglycerides and low triiodothyronine: Key risk factors for coronary artery calcification in patients with schizophrenia	110
Substance use and self-poisoning in schizophrenia: 11-year findings from a national clinical survey of suicide in mental health patients in the UK	85
Effect of add-on tDCS therapy for auditory hallucinations on frequency and duration deviant mismatch negativity in schizophrenia	82
Meta-analysis of a family history of diabetes in schizophrenia	70
Exploring associations between trait symptoms and speech patterns in schizophrenia spectrum disorders: A mediation analysis	69
Everyday function in schizophrenia: The impact of aerobic endurance and skeletal muscle strength	67
Rethinking psychosis: Time to retire “organic”, “idiopathic” and “secondary”?	60
The impact of daily social support on the associations between daily negative events and daily suspiciousness across different clinical stages of psychosis	57
Automated linguistic analysis in speech samples of Turkish-speaking patients with schizophrenia-spectrum disorders	57
Creating a collaborative culture of learning within a network of community mental health early psychosis programs in Texas	55
Interpersonal distance in schizophrenia: A systematic review	53
Neurodegenerative model of schizophrenia: Growing evidence to support a revisit	53
Deconstructing emotion regulation in schizophrenia: The nature and consequences of abnormalities in monitoring dynamics	52
Reply to Dyadic interaction in schizophrenia – A promising new avenue of investigation?	51
Can clozapine be used for treatment-refractory behavioral and psychological symptoms in dementia patients?	47
Construction of extra-large scale screening tools for risks of severe mental illnesses using real world healthcare data	45
Recovery from leukopenia after discontinuation of clozapine does not exclude lymphoma	42
Changes in degree centrality and its associated genes: A longitudinal study of patients with schizophrenia undergoing pharmacological treatment	42
Comments on the manuscript: Arthur Schopenhauer: An underappreciated philosopher in psychiatry and his applied epistemology of body and self-experience	41
Testing two theories of social support benefits and implications for individuals with psychotic-like experiences	41
Exploring the conceptualisation, measurement, clinical utility and treatment of formal thought disorder in psychosis: A Delphi study	39
Alterations in fatty acid metabolism in patients with schizophrenia in a multi-omics perspective	39
Exploring phenotypic overlap across schizotypy and autism spectrum conditions in American and Chinese young adults	38
Re-inventing the schizophrenia syndrome: The elusive “theory of everything”	38
Early cognitive development and psychopathology in children at familial high risk for schizophrenia	37

App for independence: A feasibility randomized controlled trial of a digital health tool for schizophrenia spectrum disorders	36
Polygenic risk score of glycemic homeostasis, Type 2 Diabetes Mellitus and glycemic components in first episode psychosis	36
A profile of high scores on the Peters delusion inventory and low engagement in pandemic-related health behaviors in a non-clinical sample	35
Ethno-racial variation in psychotic experiences in the United States: Findings from the National Latino and Asian American Survey and the National Survey of American Life	35
Comorbid psychosis in temporal lobe epilepsy is associated with auditory emotion recognition impairments	34
Shortening telomere is associated with psychotic dimensions in the general population	34
Searching for the “final proof” of schizophrenia	32
Going the extra mile? The influence of Amisulpride on effort-based decisions	32
A 20-year review comparing the use of ‘schizophrenia’ and ‘psychosis’ in UK newspapers from 2000 to 2019: Implications for stigma reduction	31
Associations between acceptance of the implausible bias, theory of mind and delusions in first-episode psychosis patients; A longitudinal study	30
Effects of country of origin and wave of immigration on prevalence of schizophrenia among first and second-generation immigrants: A 30-year retrospective study	30
Effect of anticholinergic burden on brain activity during Working Memory and real-world functioning in patients with schizophrenia	30
Scrutinizing the increased mortality risk associated with the use of typical oral antipsychotics	30
Overactive, aggressive, disruptive and agitated behavior associated with the use of psychotropic medications in schizophrenia	29
Selection bias in clinical studies of first-episode psychosis: A follow-up study	29
Frequency of clinical appointments in subjects with emergent suicidal ideation	28
Electroconvulsive therapy in a patient with positive anti-NMDA receptor antibodies presenting with isolated psychiatric symptoms: A case report	28
Long-term safety and effectiveness of open-label lurasidone in antipsychotic-Naïve versus previously treated adolescents with Schizophrenia: A post-hoc analysis	28
Trends in socioeconomic inequalities in incidence of severe mental illness – A population-based linkage study using primary and secondary care routinely collected data between 2000 and 2017	27
Measurement invariance of the Revised-Green Paranoid Thought Scale across Black and White Americans	27
Human endogenous retroviruses type W (HERV-) activation and schizophrenia: A meta-analysis	26
Exploring peripheral biomarkers of response to simvastatin supplementation in schizophrenia	26
Increased likelihood of distressing and functionally impairing psychotic-like experiences among children with co-occurring internalising and externalising problems	26
Association between initial clozapine titration and pneumonia risk among patients with schizophrenia in a Korean tertiary hospital	26
Denial of anosognosia in schizophrenia	26
The potential of AI for scale development: A self-report psychosis symptoms measure using ChatGPT	26
Issue Highlights	25
A systematic review of dramatherapy interventions used to support adults with psychosis	25
The schizophrenia syndrome, circa 2024: What we know and how that informs its nature	25
Abnormalities in motor adaptation to different types of perturbations in schizophreniaperturbations in schizophrenia	25
Switching a combination of first- and second-generation antipsychotic polypharmacy to antipsychotic monotherapy in long-term inpatients with schizophrenia and related disorders. The SwAP trial II: Res	25
Immunosenescence-related T cell phenotypes and white matter in schizophrenia patients with tardive dyskinesia	24
Arousal responses to personal space intrusions in psychotic illness: A virtual reality study	24
Differential gene expression study in whole blood identifies candidate genes for psychosis in African American individuals	23
Determining the cumulative incidence of treated schizophrenia and predictors of transition in an early intervention for psychosis service	23
Harnessing stem cell-based approaches for clinically meaningful discoveries in schizophrenia	23
Brief video intervention to reduce stigma of family and friends of people living with serious mental illness	23
Corrigendum to “Jang YJ, et al. Characterizing the relationship between personality dimensions and psychosis-specific clinical characteristics” [Schizophr Res. 276 (2025) 88–96 10.1016/j.schres.2025.0	23
Integrating rare variant genetics and brain transcriptome data implicates novel schizophrenia putative risk genes	23
Deciphering language disturbances in schizophrenia: A study using fine-tuned language models	23
Minority stress and schizophrenia-like experiences in sexual and gender minority adults	22
INTERACT: a randomized phase 2 study of the DAAO inhibitor luvadaxistat in adults with schizophrenia	22
Alteration in left frontoparietal connectivity correlates with impaired cognitive reappraisal in early psychosis	22
Personal recovery suits us all: A study in patients with non-affective psychosis, unaffected siblings and healthy controls	22
Insomnia and substance use in psychotic disorders	22
Mitochondrial dysfunction in psychiatric disorders	22
Relations of temporoparietal connectivity with neighborhood social fragmentation in youth at clinical high-risk for psychosis	22
Advancing the sensori-/psychomotor domain in schizophrenia spectrum disorders: From clinical observation to translational innovation	22
Effects of PDE10A inhibitor MK-8189 in people with an acute episode of schizophrenia: A randomized proof-of-concept clinical trial	22
Factors and their weight in reducing life expectancy in schizophrenia	22

The validity of atypical psychosis diagnostic criteria to detect anti-NMDA receptor encephalitis with psychiatric symptoms	21
Personal recovery in first-episode psychosis: Beyond clinical and functional recovery	21
Mismatch negativity in schizophrenia spectrum and bipolar disorders: Group and sex differences and associations with symptom severity	21
Racial microaggressions and major discriminatory events explain ethnoracial differences in psychotic experiences	21
Investigation on the association between perceived family expressed emotion, self-stigma, and subjective quality of life in people with early psychosis in Hong Kong: A cross-sectional approach	21
Mediating role of metacognitive beliefs and cognitive-attentional syndrome in the relationship between persecutory and coronavirus conspiracy beliefs in a community sample	21
Primary and secondary negative symptoms severity and the use of psychiatric care resources in schizophrenia spectrum disorders: A 3-year follow-up longitudinal retrospective study	21
Characterization and modulation of voltage-gated potassium channels in human lymphocytes in schizophrenia	21
Spontaneous neural activity underlying neutral and happy speech recognition in noise and its association with psychiatric symptoms in patients with schizophrenia	21
Decision tree classification of cognitive functions with D2 receptor occupancy and illness severity in late-life schizophrenia	21
Augmentation of learning in schizophrenia by d-serine and auditory remediation is related to auditory and frontally-generated biomarkers: A randomized, double-blind, placebo-controlled study	21
Schizophrenia among young people first admitted to psychiatric inpatient care during early and middle adolescence	20
I am a person, not an illness	20
Short-term antipsychotic treatment response in early-onset, typical-onset, and late-onset first episode schizophrenia	20
The impact of early intervention for first episode psychosis on cognitive functioning	20
COVID-19 dimensions and psychotic experiences among US college students: Findings from the Healthy Mind Study 2020	19
Promoting implementation of deployment-ready psychosocial interventions	19
Psychotic experiences predict subsequent loneliness among adolescents: A population-based birth cohort study	19
The infraslow fluctuation of sigma power during sleep in young individuals with schizophrenia	19
Perceived burdensomeness and thwarted belongingness prospectively influence real-world social support-seeking behavior among emerging adults with first-episode psychosis	19
Overview on cognitive impairment in psychotic disorders: From impaired microcircuits to dysconnectivity	19
Climatic exposures in childhood and the risk of schizophrenia from childhood to early adulthood	19
Clozapine discontinuation and rechallenge in suspected myocarditis: An analysis of seven cases	19
A call to action: Increased mortality from COVID-19 among individuals with schizophrenia calls for coordinated vaccination efforts	19
Patient-reported outcome measures in early psychosis: A cross-cultural, longitudinal examination of the self-reported health and self-reported mental health measures in Chennai, India and Montreal, Ca	18
Acceptance and Commitment Therapy-based Lifestyle Counselling Program for people with early psychosis on physical activity: A pilot randomized controlled trial	18
Assessing negative symptoms of schizophrenia in the context of remote independent ratings: a psychometric evaluation of BNSS and PANSS	18
Computational psychiatry and the psychopathology of psychosis: Promising leads and blind alleys	18
Exploring the relationship between the gut microbiota and cognitive function in schizophrenia patients with distinct weights	18
Current progress in understanding schizophrenia using genomics and pluripotent stem cells: A meta-analytical overview	18
Improving dependability in science: A critique on the psychometric qualities of the HiTOP psychosis superspectrum	18
Probing the molecular and cellular pathological mechanisms of schizophrenia using human induced pluripotent stem cell models	18
Reprint of Altered corollary discharge in the auditory cortex could reflect louder inner voice experience in patients with verbal hallucinations, a pilot fMRI study	17
Modeling common and rare genetic risk factors of neuropsychiatric disorders in human induced pluripotent stem cells	17
Redefining schizophrenia through genetics: A commentary on 50 years searching for biological causes	17
Complex chronic conditions among children born to women with schizophrenia	17
Issue highlights	17
Response to the Letter to the editor: Aripiprazole or metformin for hyperprolactinemia in women with schizophrenia: A 6-month, real-world chart review study	17
Longitudinal and cross-sectional validation of the WERCAP screen for assessing psychosis risk and conversion	17
Outcomes for first-episode psychosis after entry via an at-risk mental state clinic compared to direct entry to a first episode of psychosis service: A systematic review and meta-analysis	17
Pathways linking adverse childhood experiences to psychosis risk in Lagos, Nigeria: A structural equation modeling approach	17
Avolition predicts variability in optimal risk-taking in early psychosis	17
Disrupted static and dynamic small-world brain network topologies in patients with schizophrenia	17
Gender-specific elevation of plasma anthranilic acid in schizophrenia: Protection against glutamatergic hypofunction?	17
Issue highlights	17
Aberrant salience predicts fluctuations of paranoia two weeks in advance during a 1-year experience sampling method study in people with psychosis	16
Does affect mediate the relationship between interpersonal trauma and psychosis? A systematic review and meta-analysis	16
Hippocampal volume in affective and non-affective psychosis	16
Olfactory dysfunction in schizophrenia and other psychotic disorders: A comprehensive and updated meta-analysis	16
Do you like cliff-hangers? Objective versus subjective need for closure in the schizophrenia spectrum	16
Disparities in technology literacy and access negatively impact cognitive remediation scalability	16
Exploring the relationship between baseline health-related quality of life (AQoL-4D utility values) and mortality during long-term follow-up for people living with a psychotic disorder	16
Interoceptive functioning in schizophrenia and schizotypy	16
Multi-omics analysis reveals the impact of gut microbiota on antipsychotic-induced weight gain in schizophrenia	16
Food and nutrition insecurity among individuals with schizophrenia and related psychotic disorders	16
MicroRNA-regulated suppression of some overexpressed genes in schizophrenia and their evolutionary significance	16
Changes in social functioning over the course of psychotic disorders–A meta-analysis	16
Increased prevalence of the Heschl's gyrus duplication pattern common to various first-episode psychoses	16
Neurocognitive function and delusion severity in schizophrenia spectrum disorders	16
Association between sleep disturbances and gray matter volume in individuals at clinical high-risk for psychosis and healthy controls: A longitudinal MRI study (NAPLS-3)	16
Arthur Schopenhauer: An underappreciated philosopher in psychiatry and his applied epistemology of body and self- experience	16
The association between area-level factors and mortality in severe mental illnesses: A systematic review	16
Accessibility of psychiatric vocabulary: An international study about schizophrenia essential features	16
Editorial Board	16
Language network self-inhibition and semantic similarity in first-episode schizophrenia: A computational-linguistic and effective connectivity approach	15
Agoraphobic avoidance in patients with psychosis: Severity and response to automated VR therapy in a secondary analysis of a randomised controlled clinical trial	15
Sulfur-containing amino acids and risk of schizophrenia	15
The diagnosis and treatment of catatonia via telemedicine: A case report and proposed diagnostic criteria	15
Associations between fearlessness about death and suicidal ideation in individuals with psychosis	15
Perineuronal net density in schizophrenia: A systematic review of postmortem brain studies	15
Perceived stigma and self-stigma in young people at ultra-high risk for psychosis: Associations with identity-related, psychological and functional outcomes	15
The timing and severity of clozapine-associated neutropenia in the US: Is the risk overstated?	15
Alexithymia in chronic schizophrenia and its mediating effect between cognitive deficits and negative symptoms	15
Efficacy of KarXT on negative symptoms in acute schizophrenia: A post hoc analysis of pooled data from 3 trials	15
Identifying strategies to improve PANSS based dimensional models in schizophrenia: Accounting for multilevel structure, Bayesian model and clinical staging	15
Systematic review and meta-analysis of family-based interventions for early psychosis: Carer and patient outcomes	15
Insight and suicidality in first-episode psychosis: The mediating role of depression	15
The phenomenological nature of schizophrenia and disorder of selfhood	15
Catatonia is associated with higher rates of negative affect amongst patients with schizophrenia and schizoaffective disorder	15
Evaluating the abnormal neural variability in schizophrenia: A TMS-EEG study	14

Telomere biology and its maintenance in schizophrenia spectrum disorders: Exploring links to cognition	14
Subjective self-experiences at the mirror in patients with schizophrenia	14
Schizophrenia, the very idea: On self-disorder, hyperreflexivity, and the diagnostic concept	14
“The second I laid eyes on him I knew”: First impressions predict willingness to interact with individuals with schizophrenia	14
Psychotic-like experiences in a nationally representative study of general population adolescents	14
The introduction of clozapine at the Nathan Kline Institute in New York and its long-term consequences	14
Renaming schizophrenia in Argentina: Could a change of name resolve the stigma? Results from a national survey	14
The contributions of risk-taking and impulsivity to jumping to conclusions in the psychosis spectrum	14
Social anhedonia in the daily lives of people with schizophrenia: Examination of anticipated and consummatory pleasure	14
Longitudinal analysis of absolute neutrophil count (ANC) variability and neutropenia incidence in African American schizophrenia patients by ACKR1 genotype	14
Antineuronal antibodies in cerebrospinal fluid and serum of 104 patients with psychotic disorders compared to 104 individually matched healthy controls	14
SARPEP, a rapid-learning healthcare system of early intervention services for psychosis in Quebec, Canada: Feasibility, acceptability and early impacts	14
Defeatist beliefs about performance are important treatment targets for negative symptoms in the early course of schizophrenia	14
Young first-episode psychosis patients exhibit impaired microvascular function in the skin and low systemic nitric oxide availability, independent of classical cardiovascular risk factors	14
Pathways to care: Source of referral at first-episode psychosis, a cross-country comparison between Bologna and South London	14
Functional network interactions in patients with schizophrenia with persistent auditory verbal hallucinations: A multimodal MRI fusion approach using three-way pICA	14
Catatonia is an outpatient reality. What do we do now?	14
Learning health systems in early interventions for psychosis: Establishing consumer voices in clinical high-risk for psychosis care	14
Relationships between neuropsychological performance, insight, medication adherence, and social metacognition in schizophrenia	14
Clozapine research standards in former USSR states: A systematic review of quality issues with recommendations for future harmonization with modern research standards	14
Identifying clinical predictors for considering brain FDG-PET imaging in patients with catatonia: A case-control study	14
Relationship between psychopathological symptoms and dimensions in inpatients with schizophrenia: A network analysis	14
The role of defeatist performance beliefs on cognitive effort-cost decision-making in schizophrenia	13
Insulin resistance and lipid levels in the middle-aged offspring of parents with severe mental illness	13
COVID-19 infection, fluctuations in the clozapine/norclozapine levels and metabolic ratio and clozapine toxicity: An illustrative case-report	13
The impact of cigarette smoking on life expectancy in schizophrenia, schizoaffective disorder and bipolar affective disorder: An electronic case register cohort study	13
A role for endothelial NMDA receptors in the pathophysiology of schizophrenia	13
Automatic identification of schizophrenia employing EEG records analyzed with deep learning algorithms	13
An integrative study of the microbiome gut-brain-axis and hippocampal inflammation in psychosis: Persistent effects from mode of birth	13
A useful construct to improve the lives of people with schizophrenia	13
Sleep patterns in treated and untreated patients of schizophrenia	13
Reshaping the diagnostic borders: Historical analysis of the diagnostic changes following the introduction of the schizophrenia concept	13
Negative mood states as a correlate of cognitive performance and self-assessment of cognitive performance in bipolar disorder versus schizophrenia	13
Ultrastructural evidence for glutamatergic dysregulation in schizophrenia	13
Highlights	13
Initial evidence of vowel space reduction in a subset of individuals with schizophrenia	13
Editorial Board	13
Single trajectory treatment response for predominant negative symptoms: Post-hoc analysis of a clinical trial with cariprazine and risperidone	13
Ex vivo 1H-MRS brain metabolic profiling in a two-hit model of neurodevelopmental disorders: Prenatal immune activation and peripubertal stress	13
Early improvement as a predictor of response to blonanserin transdermal patch in patients with schizophrenia	13
Microstructural white matter biomarkers of symptom severity and therapy outcome in catatonia: Rationale, study design and preliminary clinical data of the whiteCAT study	13
Levetiracetam effects on hippocampal blood flow and symptoms in medication-free individuals with nonaffective first episode psychosis (letter)	13
Effect of schizophrenia risk gene polymorphisms on cognitive and neural plasticity	13
Decrease in gamma-band auditory steady-state response in patients with treatment-resistant schizophrenia	13
Editorial Board	13
Editorial Board	12
Reply to dynamic network analysis of schizophrenia spectrum traits, affective symptoms, and social functioning—Opportunities and challenges	12
Clozapine ultrarapid metabolism during weak induction probably exists but requires careful diagnosis. A literature review, five new cases and a proposed definition	12
Factor structure of social cognition in schizophrenia: Investigation of four core domains	12
Long-term quality of life and social disconnection 20 years after a first episode psychosis, results from the 20-year follow-up of the OPUS trial	12
Retinal electrophysiological alterations are associated with cognition in early course psychosis	12
Feasibility and Acceptability of a Physical Activity Group Program Using telerehabilitation during the COVID-19 Pandemic in Multiple early Intervention for Psychosis Services	12
Investigating bilirubin concentrations in schizophrenia: A systematic review and meta-analysis	12
Cell line specific alterations in genes associated with dopamine metabolism and signaling in midbrain dopaminergic neurons derived from 22q11.2 deletion carriers with elevated dopamine synthesis capac	12
Grey matter volume reduction in the frontotemporal cortex associated with persistent verbal auditory hallucinations in Chinese patients with chronic schizophrenia: Insights from a 3 T magnetic resonan	12
Randomized, double-blind, sham-controlled trial to evaluate the efficacy and tolerability of electroconvulsive therapy in patients with clozapine-resistant schizophrenia	12
The neuromuscular basis of functional impairment in schizophrenia: A scoping review	12
Abnormalities in emotion regulation are associated with negative, but not positive or disorganized schizotypy: An experience sampling study	12
Predicting the onset of psychotic experiences in daily life with the use of ambulatory sensor data – A proof-of-concept study	12
Why and how might yoga differ from other mind-body approaches in schizophrenia?	12
Sub-clinical systemic inflammation as a determinant of admission duration in psychosis	12
Clozapine in treatment-resistant schizophrenia: Who designed that famous US clinical trial?	12
The cellular mechanism of antipsychotic-induced myocarditis: A systematic review	12
Dynamic or not, here I come: Ambulatory assessment of psychomotor ability for clinical predictions	12
Promoting safer and wider worldwide use of clozapine	12
A psychological intervention for engaging dialogically with auditory hallucinations (Talking With Voices): A single-site, randomised controlled feasibility trial	11
Neuroanatomical subtypes of schizophrenia and relationship with illness duration and deficit status	11
Clozapine toxicity and coronavirus disease 2019: A case report	11
Epidemiology of psychotic-like experiences by subtypes and their relationship with emotional regulation and affective lability among Chinese college students	11
Self and time in individuals with schizophrenia: A motor component?	11
Toxoplasmosis infection and schizophrenia: Elevated IgM reactivity index as a predictor of symptom worsening in chronic schizophrenia	11
Combining cognitive behavioral therapy and group training for social skills and cognition to improve negative symptoms in patients with psychotic disorders: a randomized controlled pilot trial	11
A systematic chart review of pharmacological interventions in patients with clozapine-induced hypersalivation	11
Prenatal infection and schizophrenia: A decade of further progress	11
Cognitive-Behavioral Social Skills Training for patients with late-life schizophrenia and the moderating effect of executive dysfunction	11
Treatment resistance NMDA receptor pathway polygenic score is associated with brain glutamate in schizophrenia	11
Can peripheral brain-derived neurotrophic factor (BDNF) be a potential biomarker of suicide risk in schizophrenia?	11
Editorial Board	11
The unfulfilled promise of equitable first episode care for Black-Americans: A way forward	11
Reframing schizophrenia: Altering our perceptions?	11
The use of adaptive emotion regulation strategies in people with attenuated psychotic symptoms – Results from a two-week diary study	11
Letter to the editor regarding: Dynamic network analysis of schizophrenia spectrum traits, affective symptoms, and social functioning—Opportunities and challenges	11
Clozapine treatment and astrocyte activity in treatment resistant schizophrenia: A proton magnetic resonance spectroscopy study	11
Negative symptoms in schizophrenia: Newly emerging measurements, pathways, and treatments	11
Obsessive-compulsive symptoms and personal recovery in patients with schizophrenia spectrum disorders: A cross-sectional study	11
Editorial Board	11
‘Thinking about Them is only making me feel worse’. The mediating role of metacognitive factors in the relationship between paranoia-like beliefs and psychopathology symptoms in a community sample	11
Editorial Board	11
Attention-deficit/hyperactivity disorder in youth with psychosis spectrum symptoms	11
Utilization of a psychosis consultation service: Early lessons from a statewide initiative	11
Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and meta-analysis of individual patient data	11
Not socially blind: Unimpaired perception of social interaction in schizophrenia	11
High rates of myocarditis with clozapine in the Hunter region of Australia	11
Everything is connected: Inference and attractors in delusions	11
The role of glutamate and GABA in cognitive dysfunction in schizophrenia and mood disorders – A systematic review of magnetic resonance spectroscopy studies	10